These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11363834)

  • 21. List of studies - October 1996. University of Washington AIDS Clinical Trials Unit.
    STEP Perspect; 1996; 8(3):17-8. PubMed ID: 11364266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antiretroviral therapy of acquired immunodeficiency syndrome (AIDS)].
    Jevtović Dj; Ranin J; Salemović D; Brmbolić B; Zerjav S
    Srp Arh Celok Lek; 1992 Nov; 120 Suppl 5():38-41. PubMed ID: 18170976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ICAAC and Hamburg: Part 2. The dry salvages or, what to do with two protease inhibitors.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1997 Dec; 3(12):39-54. PubMed ID: 11364944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. List of studies - October 1997. University of Washington AIDS Clinical Trials Unit.
    STEP Perspect; 1998; 98(1):24-5. PubMed ID: 11365213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to mix a cocktail.
    Dunable D
    Surviv News (Atlanta Ga); 1998 May; ():13, 17. PubMed ID: 11365365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New data on IL-2.
    Whitson S
    Posit Aware; 1998; 9(4):52. PubMed ID: 11365633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term virological outcome in patients infected with multi-nucleoside analogue-resistant HIV-1.
    Clevenbergh P; Kirstetter M; Liotier JY; Dupon M; Philibert P; Jacomet C; Cua E; Montagne N; Schmit JC; Dellamonica P
    Antivir Ther; 2002 Dec; 7(4):305-8. PubMed ID: 12553486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whatever happened to expanded access?
    Notes Undergr; 1997; (No 35):2-3. PubMed ID: 11364564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDA approves an AIDS drug from Vertex. Food and Drug Administration.
    Newsline People AIDS Coalit N Y; 1999; ():32. PubMed ID: 11367345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study.
    Mocroft A; Phillips AN; Friis-Møller N; Colebunders R; Johnson AM; Hirschel B; Saint-Marc T; Staub T; Clotet B; Lundgren JD;
    Antivir Ther; 2002 Mar; 7(1):21-30. PubMed ID: 12008784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunistic disease and other condition studies open for enrollment--August 1996. University of Washington AIDS Clinical Trials Unit.
    STEP Perspect; 1996; 8(2):18-9. PubMed ID: 11364262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Designing anti-AIDS drugs targeting the major mechanism of HIV-1 RT resistance to nucleoside analog drugs.
    Sarafianos SG; Hughes SH; Arnold E
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1706-15. PubMed ID: 15183339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New York ADAP to cover new AIDS drugs plus viral load testing.
    Link D
    GMHC Treat Issues; 1996 Sep; 10(9):12. PubMed ID: 11363840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New formulation of saquinavir (Fortovase) is more effective.
    Tam CW
    Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance of genotypic resistance mutations in chronic HIV-1 treated individuals after completion of the National Access to Antiretroviral Program in Thailand.
    Sukasem C; Churdboonchart V; Chasombat S; Kohreanudom S; Watitpun C; Pasomsub E; Piroj W; Tiensuwan M; Chantratita W
    Infection; 2007 Apr; 35(2):81-8. PubMed ID: 17401711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental treatments for HIV and AIDS.
    AIDS Inst Newsl; 1995 Jun; ():1-5. PubMed ID: 11367410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Federal AIDS policy issues today.
    James JS
    AIDS Treat News; 1997 Aug; (No 276):2-8. PubMed ID: 11364520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Philadelphia area AIDS/HIV clinical trials.
    Crit Path AIDS Proj; 1998; (No 33):35-43. PubMed ID: 11366372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raltegravir: the first HIV integrase inhibitor.
    Cocohoba J; Dong BJ
    Clin Ther; 2008 Oct; 30(10):1747-65. PubMed ID: 19014832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.